Resumes
Resumes
Rikki Waterhouse Chester, NH
View pageWork:
PET Radiotracer for the Glycine Site
2014 to 2000
Imaging Biol
2014 to 2000
Imaging Biol
Feb 2012 to 2014
Brai JR
Journal of Labelled
2002 to 2013
Imaging
2010 to 2010
PET. J Nucl Med
2008 to 2009
Nucl Med Biol
2008 to Jan 2008
Atuehene N
Jul 2007 to Jul 2007
Neuroprotection
2007 to 2007
18F SFE. Mol Imaging Biol
2006 to 2006
Radiopharmaceuticals
Jan 2005 to Feb 2005
PET radiotracer for the NMDA
2004 to 2004
Medicine and Biology
2003 to 2003
Agonist Properties at Central Benzodiazepine Receptors
2003 to 2003
Receptor Radiotracer
2003 to 2003
Labelled Compound and Radiopharmaceuticals
2003 to 2003
Methods in Physics Research Part A
2003 to 2003
R.N. Imaging the PCP Site of the NMDA Ion Channel
2003 to 2003
Compound and Radiopharmaceuticals
2002 to 2002
Breast Cancer Research and Treatment
2002 to 2002
Annual Meeting, NIH
Bethesda, MD
Jul 2001 to Jul 2001
Opioid Antagonist
2001 to 2001
Nuclear Medicine Communications
2001 to 2001
Radiopharmacueticals for Diagnosis and Therapy
2001 to 2001
Drug Development Year
Investigations of Delta
1998 to 1998
Models
1997 to 1997
A Selective Sigma
1997 to 1997
Medicine and Biology
1997 to 1997
Phenoxymethyl
1997 to 1997
Patz E. F. Jr
Radiopharmaceuticals
1996 to 1996
MI USA
1993 to 1993
W. Eds
Knoxville, TN
1992 to 1992
Nuclear Compact
1990 to 1990
R.N. Imaging the PCP Site of the NMDA Ion Channel
Madrid, Madrid
May 2003 to Present
2014 to 2000
Imaging Biol
2014 to 2000
Imaging Biol
Feb 2012 to 2014
Brai JR
Journal of Labelled
2002 to 2013
Imaging
2010 to 2010
PET. J Nucl Med
2008 to 2009
Nucl Med Biol
2008 to Jan 2008
Atuehene N
Jul 2007 to Jul 2007
Neuroprotection
2007 to 2007
18F SFE. Mol Imaging Biol
2006 to 2006
Radiopharmaceuticals
Jan 2005 to Feb 2005
PET radiotracer for the NMDA
2004 to 2004
Medicine and Biology
2003 to 2003
Agonist Properties at Central Benzodiazepine Receptors
2003 to 2003
Receptor Radiotracer
2003 to 2003
Labelled Compound and Radiopharmaceuticals
2003 to 2003
Methods in Physics Research Part A
2003 to 2003
R.N. Imaging the PCP Site of the NMDA Ion Channel
2003 to 2003
Compound and Radiopharmaceuticals
2002 to 2002
Breast Cancer Research and Treatment
2002 to 2002
Annual Meeting, NIH
Bethesda, MD
Jul 2001 to Jul 2001
Opioid Antagonist
2001 to 2001
Nuclear Medicine Communications
2001 to 2001
Radiopharmacueticals for Diagnosis and Therapy
2001 to 2001
Drug Development Year
Investigations of Delta
1998 to 1998
Models
1997 to 1997
A Selective Sigma
1997 to 1997
Medicine and Biology
1997 to 1997
Phenoxymethyl
1997 to 1997
Patz E. F. Jr
Radiopharmaceuticals
1996 to 1996
MI USA
1993 to 1993
W. Eds
Knoxville, TN
1992 to 1992
Nuclear Compact
1990 to 1990
R.N. Imaging the PCP Site of the NMDA Ion Channel
Madrid, Madrid
May 2003 to Present
Education:
Columbia University College of Physicians & Surgeons
New York, NY
Jun 2005 to Jul 2006
Clinical Neuroscience
College of Physicians & Surgeons
New York, NY
2004 to 2005
Neuroscience
Columbia University
1998 to 2004
Neuroscience
Duke University
Durham, NC
1997 to 1998
Research Professor
University of TN
1993
Ph.D. in Chemistry
University of TN
1988
B.A. in Chemistry
New York, NY
Jun 2005 to Jul 2006
Clinical Neuroscience
College of Physicians & Surgeons
New York, NY
2004 to 2005
Neuroscience
Columbia University
1998 to 2004
Neuroscience
Duke University
Durham, NC
1997 to 1998
Research Professor
University of TN
1993
Ph.D. in Chemistry
University of TN
1988
B.A. in Chemistry